Aurobindo Pharma | ARBP - Current Liabilities

Stock Price
1,413.80
Daily Change
-22.10 -1.54%
Monthly
8.11%
Yearly
16.09%
Q2 Forecast
1,382.70

Aurobindo Pharma reported INR155.01B in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Cipla INR 62.97B 8.13B Sep/2025
Divis Laboratories Ltd INR 17.28B 2.76B Sep/2025
Dr.Reddys Laboratories INR 158.31B 7.38B Dec/2025
Hindustan Unilever INR 184.28B 18.91B Sep/2025
Sun Pharmaceuticals INR 234.15B 52.21B Sep/2025
UPL INR 330.9B 45.21B Sep/2025